BREAKING NEWS

Teva to start selling generic Viagra in US in 2017 after agreement with Pfizer

By GLOBES CORRESPONDENT

DECEMBER 18, 2013 11:10

Israeli pharmaceutical giant Teva has entered into an agreement with Pfizer Inc. to settle patent litigation related to Teva's generic version of Pfizer's Viagra tablets.

Under the terms of the agreement, Teva said that it will be able to launch its Abbreviated New Drug Application (ANDA) products pursuant to a royalty-bearing license on December 11, 2017, or earlier under certain circumstances. The terms of the settlement agreement are otherwise confidential.

The US Food and Drug Administration (FDA) has already granted tentative approval for Teva's generic version of Pfizer's 25, 50, and 100 mg. Viagra tablets.

Viagra had annual sales of $1.2 billion in the US, based on IMS sales data as of September 2013.

Two Palestinians were shot dead after trying to break through checkpoint

By JERUSALEM POST STAFF

04/27/2024 04:37 AM

IDF strikes Khan Yunis, Rafah and Nuseirat

By JERUSALEM POST STAFF

04/27/2024 04:30 AM

IDF: Mt Hermon targeted by 30 launches, no known casualties

By JERUSALEM POST STAFF

04/26/2024 09:34 PM

Pentagon chief: Iran should question strategy after Israel attack failed

By REUTERS